Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer

Clinical trial NCT00263822 · COMPLETED

Trial details

NCT number: NCT00263822
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Fallopian Tube Cancer Ovarian Cancer Primary Peritoneal Cavity Cancer

Start date: 2005-09-01
Primary completion: 2008-02-01
Enrollment: 835

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.